150 related articles for article (PubMed ID: 22438026)
21. Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy.
Nahata L; Sivaraman V; Quinn GP
Fertil Steril; 2016 Nov; 106(6):1470-1474. PubMed ID: 27521770
[TBL] [Abstract][Full Text] [Related]
22. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.
Lawrenz B; Henes J; Henes M; Neunhoeffer E; Schmalzing M; Fehm T; Kïtter I
Lupus; 2011 Oct; 20(11):1193-7. PubMed ID: 21768179
[TBL] [Abstract][Full Text] [Related]
23. Possibilities of fertility preservation in young patients with ovarian cancer.
Henes M; Neis F; Krämer B; Walter C; Brucker S; Von Wolff M; Rothmund R; Lawrenz B; Rall K
Anticancer Res; 2014 Jul; 34(7):3851-4. PubMed ID: 24982413
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
25. Fertility preservation in prepubertal girls prior to chemotherapy and radiotherapy--review of the literature.
Lawrenz B; Rothmund R; Neunhoeffer E; Huebner S; Henes M
J Pediatr Adolesc Gynecol; 2012 Oct; 25(5):284-8. PubMed ID: 21872516
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and attitudes of women in relation to chosen fertility preservation techniques: a prospective, multicenter questionnaire-based study with 144 participants.
von Wolff M; Giesecke D; Germeyer A; Lawrenz B; Henes M; Nawroth F; Friebel S; Rohde A; Giesecke P; Denschlag D
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():12-7. PubMed ID: 27039248
[TBL] [Abstract][Full Text] [Related]
27. Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.
von Wolff M; Montag M; Dittrich R; Denschlag D; Nawroth F; Lawrenz B
Arch Gynecol Obstet; 2011 Aug; 284(2):427-35. PubMed ID: 21431846
[TBL] [Abstract][Full Text] [Related]
28. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
Blumenfeld Z
Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
[TBL] [Abstract][Full Text] [Related]
29. Fertility sparing in cancer patients.
Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J
Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808
[TBL] [Abstract][Full Text] [Related]
30. Ovarian function and reproductive outcomes of female patients with systemic lupus erythematosus and the strategies to preserve their fertility.
Oktem O; Guzel Y; Aksoy S; Aydin E; Urman B
Obstet Gynecol Surv; 2015 Mar; 70(3):196-210. PubMed ID: 25769434
[TBL] [Abstract][Full Text] [Related]
31. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques.
von Wolff M; Germeyer A; Liebenthron J; Korell M; Nawroth F
Arch Gynecol Obstet; 2018 Jan; 297(1):257-267. PubMed ID: 29181578
[TBL] [Abstract][Full Text] [Related]
32. Gonadal failure with cyclophosphamide therapy for lupus nephritis: advances in fertility preservation.
Mersereau J; Dooley MA
Rheum Dis Clin North Am; 2010 Feb; 36(1):99-108, viii. PubMed ID: 20202593
[TBL] [Abstract][Full Text] [Related]
33. [Immunosuppressive therapy and fertility preservation: Indications and methods].
Choux C; Cavalieri M; Barberet J; Samson M; Bonnotte B; Fauque P; Sagot P
Rev Med Interne; 2018 Jul; 39(7):557-565. PubMed ID: 29500075
[TBL] [Abstract][Full Text] [Related]
34. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation.
von Wolff M; Donnez J; Hovatta O; Keros V; Maltaris T; Montag M; Salle B; Sonmezer M; Andersen CY
Eur J Cancer; 2009 Jun; 45(9):1547-53. PubMed ID: 19264478
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N
J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
[TBL] [Abstract][Full Text] [Related]
36. [Ovarian function in systemic lupus erythematosus patients undergoing the use of cyclophosphamide in two major rheumatologic care centers in Curitiba, Paraná State].
Paviani G; Pasetto CV; Hul BH; Rachid Filho A; Skare TL; Kulak Junior J
Rev Bras Ginecol Obstet; 2015 Jun; 37(6):272-7. PubMed ID: 26200825
[TBL] [Abstract][Full Text] [Related]
37. Cyclophosphamide boluses induce micronuclei expression in buccal mucosa cells of patients with systemic lupus erythematosus independent of cytochrome P450 2D6 status.
Aceves Avila FJ; Esquivel Nava GA; Gallegos Arreola MP; Gómez Meda B; Zúñiga González G; Ramos-Remus C
J Rheumatol; 2004 Jul; 31(7):1335-9. PubMed ID: 15229952
[TBL] [Abstract][Full Text] [Related]
38. [Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy].
Yang XY; Zhu X; Liang LQ; Zhan ZP; Ye YJ
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):960-2. PubMed ID: 16061002
[TBL] [Abstract][Full Text] [Related]
39. Combination of fertility preservation strategies in young women with recently diagnosed cancer.
Huser M; Zakova J; Smardova L; Crha I; Janku P; Hudecek R; Ventruba P
Eur J Gynaecol Oncol; 2012; 33(1):42-50. PubMed ID: 22439404
[TBL] [Abstract][Full Text] [Related]
40. Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia.
Alarfaj AS; Khalil N
Clin Rheumatol; 2014 Dec; 33(12):1731-6. PubMed ID: 24894105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
